Select Pharmaceuticals Portfolio

Fund Profile

Fund profile

Tickers

FPHAX

Fund manager

Fidelity Select Technology Portfolio

Total assets

$1.44 bn

Liabilities

$16.81 mm

Net assets

$1.42 bn

Number of holdings

63.00

63 Holdings

As of Nov 2024

Security	$Holding	Balance	% of Fund	Category	Position	Country
LLY Eli Lilly and Company	356.76 mm	448.56 k shares	25.04	Common equity	Long	USA
NVO Novo Nordisk A/S	226.27 mm	2.12 mm shares	15.88	Common equity	Long	Denmark
ASTRAZENECA PLC SPONS ADR	131.32 mm	1.94 mm shares	9.22	Common equity	Long	UK
UCB SA	70.83 mm	361.60 k shares	4.97	Common equity	Long	Belgium
MRK Merck & Co., Inc.	69.08 mm	679.64 k shares	4.85	Common equity	Long	USA
GSK PLC SPONS ADR	69.06 mm	2.02 mm shares	4.85	Common equity	Long	UK
GILD Gilead Sciences, Inc.	58.22 mm	628.90 k shares	4.09	Common equity	Long	USA
LEGN Legend Biotech Corporation	50.19 mm	1.19 mm shares	3.52	Common equity	Long	Cayman Islands
BMY Bristol-Myers Squibb Company	34.66 mm	585.20 k shares	2.43	Common equity	Long	USA
Fidelity Cash Central Fund	30.35 mm	30.34 mm shares	2.13	Short-term investment vehicle	Long	USA
ELAN Elanco Animal Health Incorporated	30.06 mm	2.28 mm shares	2.11	Common equity	Long	USA
ROYALTY PHARMA PLC	28.38 mm	1.06 mm shares	1.99	Common equity	Long	UK
RNA Avidity Biosciences, Inc.	24.11 mm	560.20 k shares	1.69	Common equity	Long	USA
ZTS Zoetis Inc.	18.30 mm	104.40 k shares	1.28	Common equity	Long	USA
BNTX BioNTech SE	16.63 mm	140.45 k shares	1.17	Common equity	Long	Germany
DYN Dyne Therapeutics, Inc.	15.78 mm	515.40 k shares	1.11	Common equity	Long	USA
Fidelity Securities Lending Cash Central Fund	15.77 mm	15.77 mm shares	1.11	Short-term investment vehicle	Long	USA
MERCK KGAA	14.78 mm	98.80 k shares	1.04	Common equity	Long	Germany
MRNA Moderna, Inc.	13.07 mm	303.50 k shares	0.92	Common equity	Long	USA
RCUS Arcus Biosciences, Inc.	11.73 mm	760.00 k shares	0.82	Common equity	Long	USA
FINANCIERE DE TUBIZE SA	11.55 mm	79.30 k shares	0.81	Common equity	Long	Belgium
XENE Xenon Pharmaceuticals Inc.	11.52 mm	270.20 k shares	0.81	Common equity	Long	Canada
PTCT PTC Therapeutics, Inc.	10.65 mm	242.80 k shares	0.75	Common equity	Long	USA
LUNG Pulmonx Corporation	9.56 mm	1.48 mm shares	0.67	Common equity	Long	USA
SRPT Sarepta Therapeutics, Inc.	9.47 mm	71.00 k shares	0.66	Common equity	Long	USA
GALDERMA GROUP AG	9.45 mm	92.24 k shares	0.66	Common equity	Long	Switzerland
IRON Disc Medicine, Inc.	6.53 mm	102.90 k shares	0.46	Common equity	Long	USA
ION BEAM APPLICATIONS SA REG	6.23 mm	422.40 k shares	0.44	Common equity	Long	Belgium
BPMC Blueprint Medicines Corporation	5.58 mm	57.90 k shares	0.39	Common equity	Long	USA
CTLT Catalent, Inc.	5.44 mm	89.10 k shares	0.38	Common equity	Long	USA
MERUS B.V.	5.26 mm	117.40 k shares	0.37	Common equity	Long	Netherlands
ASND Ascendis Pharma A/S	4.91 mm	36.10 k shares	0.34	Common equity	Long	Denmark
SUMMIT THERAPEUTICS INC PIPE	4.88 mm	264.32 k shares	0.34	Common equity	Long	USA
AXSM Axsome Therapeutics, Inc.	4.86 mm	49.50 k shares	0.34	Common equity	Long	USA
HRMY Harmony Biosciences Holdings, Inc.	4.53 mm	130.68 k shares	0.32	Common equity	Long	USA
OCUL Ocular Therapeutix, Inc.	4.23 mm	427.50 k shares	0.30	Common equity	Long	USA
BEAM Beam Therapeutics Inc.	4.06 mm	148.20 k shares	0.28	Common equity	Long	USA
ARRIVENT BIOPHARMA INC	3.86 mm	128.70 k shares	0.27	Common equity	Long	USA
METSERA INC SER B PC PP	3.30 mm	654.81 k shares	0.23	Preferred equity	Long	USA
SYRE Spyre Therapeutics, Inc.	3.04 mm	106.94 k shares	0.21	Common equity	Long	USA
EWTX Edgewise Therapeutics, Inc.	2.76 mm	83.60 k shares	0.19	Common equity	Long	USA
NTLA Intellia Therapeutics, Inc.	2.70 mm	172.90 k shares	0.19	Common equity	Long	USA
NYXOAH SA	2.42 mm	298.20 k shares	0.17	Common equity	Long	Belgium
NYXOAH SA	2.13 mm	257.88 k shares	0.15	Common equity	Long	Belgium
PARAGON BIOSCIENCES EMALEX CAPITAL INC SER C PC PP	1.98 mm	158.88 k shares	0.14	Preferred equity	Long	USA
AGOMAB THERAPEUTICS SA SER D PC PP	1.94 mm	7.65 k shares	0.14	Preferred equity	Long	Belgium
AGOMAB THERAPEUTICS SA SER C PC PP	1.90 mm	7.73 k shares	0.13	Preferred equity	Long	Belgium
CASTLE CREEK BIOSCIENCES INC SER D-1 PC PP	1.40 mm	6.31 k shares	0.10	Preferred equity	Long	USA
PROTHENA CORP PLC	1.23 mm	75.80 k shares	0.09	Common equity	Long	Ireland
EVOZYNE INC CPIK 6% 09/13/2028 P/P	1.03 mm	935.57 k principal	0.07	Debt	Long	USA
GLPG Galapagos NV	1.02 mm	36.90 k shares	0.07	Common equity	Long	Belgium
EVOZYNE INC SER B PC PP	959.53 k	56.64 k shares	0.07	Preferred equity	Long	USA
ARVN Arvinas, Inc.	702.74 k	26.30 k shares	0.05	Common equity	Long	USA
GBIO Generation Bio Co.	428.47 k	281.89 k shares	0.03	Common equity	Long	USA
PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-2 PC PP	267.70 k	22.48 k shares	0.02	Preferred equity	Long	USA
PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-1 PC PP	180.00 k	14.40 k shares	0.01	Preferred equity	Long	USA
EVOZYNE INC SER A PC PP	98.06 k	5.90 k shares	0.01	Preferred equity	Long	USA
CASTLE CREEK BIOSCIENCES INC SER C PC PERP PP	49.38 k	200.00 shares	0.00	Preferred equity	Long	USA
CASTLE CREEK BIOSCIENCES INC SER D-2 PC PP	16.85 k	85.00 shares	0.00	Preferred equity	Long	USA
LEAP THERAPEUTICS INC WT	24.24	60.60 k shares	0.00	Common equity	Long	USA
MEDAVAIL HOLDINGS INC PIPE	0.01	66.00 shares	0.00	Common equity	Long	USA
AGOMAB THERAPEUTICS SA ANTI-DILUTION WT PP 11/04/2034	0	10.00 shares	0.00	Common equity	Long	Belgium
AGOMAB THERAPEUTICS SA ANTI-DILUTION WT PP 10/10/2033	0	10.00 shares	0.00	Common equity	Long	Belgium